Review



c. diff quik chek complete  (TechLab Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    TechLab Inc c. diff quik chek complete
    C. Diff Quik Chek Complete, supplied by TechLab Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/diff-quik+staining+method/c++diff+quik+chek+complete/pm24674056-87-42-47
    Average 90 stars, based on 1 article reviews
    c. diff quik chek complete - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection.
    Article Snippet: TABLE 1 Detection of GDH and toxins A/B with three rapid immunoassays compared to tcdA detection with the Alethia C. difficile (Meridian) Consecutive samples, n = 57 Frozen samples (positive with Alethia), n = 47 Alethia C. difficile (Meridian) 14 47 C. diff Quik Chek Complete (Techlab) GDH 14 43 Toxin A/B 10 26 Clostridium difficile GDH + Toxin A + B (Certest) GDH 14/1a 42 Toxin A/B 7/1a 18 Immunocard STAT!

    Article Title: Antibiotic De-Escalation in the Intensive Care Unit: Rationale and Potential Strategies
    Article Snippet: Enzyme immunoassay , Enzyme-linked immunosorbent assay , Techlab C. Diff Quik Chek Complete , Stool , 1 , .

    Article Title: Clinical and Microbiological Characteristics of Hospitalized Adults Aged ≤ 45 Years With Clostridioides (Formerly Clostridium ) difficile Infection: A Prospective Observational Cohort Study From Hungary
    Article Snippet: Diagnosis was made by a clinically compatible case presentation (diarrhea, ileus, toxic megacolon or CDI associated sepsis) plus confirmation of a toxin‐producing C. difficile strain from an unformed stool sample, using enzyme immuno‐assay targeting glutamate dehydrogenase and toxins A + B (C. Diff Quik Chek Complete, TECHLAB Inc.) [ ].

    Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection.
    Article Snippet: In this study, we evaluated the C. diff Quik Chek Complete (TechLab, Blacksburg, Virginia, USA), the CerTest Clostridium difficile GDH +Toxin A + B (CerTest, San Mateo de Gállego, Zaragoza, Spain), and the ImmunoCard STAT!

    Article Title: Impact of the COVID-19 Pandemic on Clostridioides difficile Infection Rates in a Tertiary Hospital: A Retrospective Comparative Study
    Article Snippet: Initial screening used the TECHLAB® C. DIFF QUIK CHEK COMPLETETM to detect glutamate dehydrogenase (GDH) antigen and Toxins A and B.

    Article Title: Risk factors for the development of Clostridioides difficile infection in patients colonized with toxigenic Clostridioides difficile
    Article Snippet: Testing for CDI was performed on unformed stool samples using a two-step algorithm; glutamate dehydrogenase (GDH) testing followed by confirmatory EIA (C. Diff Quik Chek Complete; TechLab, Blacksburg, VA), consistent with guideline-recommended algorithms by performing a highly sensitive test first, followed by a highly specific test.

    Article Title: Shigella flexneri Outbreak at a Rehabilitation Center: First Report from Saudi Arabia.
    Article Snippet: Additionally, the stool tested negative for Clostridium difficile toxin using C. DIFF QUIK CHEK COMPLETE ® (TECHLAB, Inc., Blacksburg, VA, USA) on three different samples collected on different days.

    Article Title: Evaluation of a Fluorescence Immunoassay for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxin Antigens.
    Article Snippet: Samples were concurrently tested using the Sofia 2 C. difficile FIA (Sofia 2, QuidelOrtho) and C. diff Quik Chek Complete (QCC, Techlab Inc.).

    Diff-Quik:

    Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection.
    Article Snippet: TABLE 1 Detection of GDH and toxins A/B with three rapid immunoassays compared to tcdA detection with the Alethia C. difficile (Meridian) Consecutive samples, n = 57 Frozen samples (positive with Alethia), n = 47 Alethia C. difficile (Meridian) 14 47 C. diff Quik Chek Complete (Techlab) GDH 14 43 Toxin A/B 10 26 Clostridium difficile GDH + Toxin A + B (Certest) GDH 14/1a 42 Toxin A/B 7/1a 18 Immunocard STAT!

    Article Title: Antibiotic De-Escalation in the Intensive Care Unit: Rationale and Potential Strategies
    Article Snippet: Enzyme immunoassay , Enzyme-linked immunosorbent assay , Techlab C. Diff Quik Chek Complete , Stool , 1 , .

    Article Title: Clinical and Microbiological Characteristics of Hospitalized Adults Aged ≤ 45 Years With Clostridioides (Formerly Clostridium ) difficile Infection: A Prospective Observational Cohort Study From Hungary
    Article Snippet: Diagnosis was made by a clinically compatible case presentation (diarrhea, ileus, toxic megacolon or CDI associated sepsis) plus confirmation of a toxin‐producing C. difficile strain from an unformed stool sample, using enzyme immuno‐assay targeting glutamate dehydrogenase and toxins A + B (C. Diff Quik Chek Complete, TECHLAB Inc.) [ ].

    Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection.
    Article Snippet: In this study, we evaluated the C. diff Quik Chek Complete (TechLab, Blacksburg, Virginia, USA), the CerTest Clostridium difficile GDH +Toxin A + B (CerTest, San Mateo de Gállego, Zaragoza, Spain), and the ImmunoCard STAT!

    Article Title: Impact of the COVID-19 Pandemic on Clostridioides difficile Infection Rates in a Tertiary Hospital: A Retrospective Comparative Study
    Article Snippet: Initial screening used the TECHLAB® C. DIFF QUIK CHEK COMPLETETM to detect glutamate dehydrogenase (GDH) antigen and Toxins A and B.

    Article Title: Risk factors for the development of Clostridioides difficile infection in patients colonized with toxigenic Clostridioides difficile
    Article Snippet: Testing for CDI was performed on unformed stool samples using a two-step algorithm; glutamate dehydrogenase (GDH) testing followed by confirmatory EIA (C. Diff Quik Chek Complete; TechLab, Blacksburg, VA), consistent with guideline-recommended algorithms by performing a highly sensitive test first, followed by a highly specific test.

    Article Title: Shigella flexneri Outbreak at a Rehabilitation Center: First Report from Saudi Arabia.
    Article Snippet: Additionally, the stool tested negative for Clostridium difficile toxin using C. DIFF QUIK CHEK COMPLETE ® (TECHLAB, Inc., Blacksburg, VA, USA) on three different samples collected on different days.

    Article Title: Evaluation of a Fluorescence Immunoassay for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxin Antigens.
    Article Snippet: Samples were concurrently tested using the Sofia 2 C. difficile FIA (Sofia 2, QuidelOrtho) and C. diff Quik Chek Complete (QCC, Techlab Inc.).

    Biomarker Discovery:

    Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection.
    Article Snippet: TABLE 1 Detection of GDH and toxins A/B with three rapid immunoassays compared to tcdA detection with the Alethia C. difficile (Meridian) Consecutive samples, n = 57 Frozen samples (positive with Alethia), n = 47 Alethia C. difficile (Meridian) 14 47 C. diff Quik Chek Complete (Techlab) GDH 14 43 Toxin A/B 10 26 Clostridium difficile GDH + Toxin A + B (Certest) GDH 14/1a 42 Toxin A/B 7/1a 18 Immunocard STAT!

    Article Title: Antibiotic De-Escalation in the Intensive Care Unit: Rationale and Potential Strategies
    Article Snippet: Enzyme immunoassay , Enzyme-linked immunosorbent assay , Techlab C. Diff Quik Chek Complete , Stool , 1 , .

    Article Title: Clinical and Microbiological Characteristics of Hospitalized Adults Aged ≤ 45 Years With Clostridioides (Formerly Clostridium ) difficile Infection: A Prospective Observational Cohort Study From Hungary
    Article Snippet: Diagnosis was made by a clinically compatible case presentation (diarrhea, ileus, toxic megacolon or CDI associated sepsis) plus confirmation of a toxin‐producing C. difficile strain from an unformed stool sample, using enzyme immuno‐assay targeting glutamate dehydrogenase and toxins A + B (C. Diff Quik Chek Complete, TECHLAB Inc.) [ ].

    Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection.
    Article Snippet: In this study, we evaluated the C. diff Quik Chek Complete (TechLab, Blacksburg, Virginia, USA), the CerTest Clostridium difficile GDH +Toxin A + B (CerTest, San Mateo de Gállego, Zaragoza, Spain), and the ImmunoCard STAT!

    Article Title: Impact of the COVID-19 Pandemic on Clostridioides difficile Infection Rates in a Tertiary Hospital: A Retrospective Comparative Study
    Article Snippet: Initial screening used the TECHLAB® C. DIFF QUIK CHEK COMPLETETM to detect glutamate dehydrogenase (GDH) antigen and Toxins A and B.

    Article Title: Risk factors for the development of Clostridioides difficile infection in patients colonized with toxigenic Clostridioides difficile
    Article Snippet: Testing for CDI was performed on unformed stool samples using a two-step algorithm; glutamate dehydrogenase (GDH) testing followed by confirmatory EIA (C. Diff Quik Chek Complete; TechLab, Blacksburg, VA), consistent with guideline-recommended algorithms by performing a highly sensitive test first, followed by a highly specific test.

    Article Title: Shigella flexneri Outbreak at a Rehabilitation Center: First Report from Saudi Arabia.
    Article Snippet: Additionally, the stool tested negative for Clostridium difficile toxin using C. DIFF QUIK CHEK COMPLETE ® (TECHLAB, Inc., Blacksburg, VA, USA) on three different samples collected on different days.

    Article Title: Evaluation of a Fluorescence Immunoassay for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxin Antigens.
    Article Snippet: Samples were concurrently tested using the Sofia 2 C. difficile FIA (Sofia 2, QuidelOrtho) and C. diff Quik Chek Complete (QCC, Techlab Inc.).

    Immuno Assay:

    Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection.
    Article Snippet: TABLE 1 Detection of GDH and toxins A/B with three rapid immunoassays compared to tcdA detection with the Alethia C. difficile (Meridian) Consecutive samples, n = 57 Frozen samples (positive with Alethia), n = 47 Alethia C. difficile (Meridian) 14 47 C. diff Quik Chek Complete (Techlab) GDH 14 43 Toxin A/B 10 26 Clostridium difficile GDH + Toxin A + B (Certest) GDH 14/1a 42 Toxin A/B 7/1a 18 Immunocard STAT!

    Article Title: Antibiotic De-Escalation in the Intensive Care Unit: Rationale and Potential Strategies
    Article Snippet: Enzyme immunoassay , Enzyme-linked immunosorbent assay , Techlab C. Diff Quik Chek Complete , Stool , 1 , .

    Article Title: Clinical and Microbiological Characteristics of Hospitalized Adults Aged ≤ 45 Years With Clostridioides (Formerly Clostridium ) difficile Infection: A Prospective Observational Cohort Study From Hungary
    Article Snippet: Diagnosis was made by a clinically compatible case presentation (diarrhea, ileus, toxic megacolon or CDI associated sepsis) plus confirmation of a toxin‐producing C. difficile strain from an unformed stool sample, using enzyme immuno‐assay targeting glutamate dehydrogenase and toxins A + B (C. Diff Quik Chek Complete, TECHLAB Inc.) [ ].

    Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection.
    Article Snippet: In this study, we evaluated the C. diff Quik Chek Complete (TechLab, Blacksburg, Virginia, USA), the CerTest Clostridium difficile GDH +Toxin A + B (CerTest, San Mateo de Gállego, Zaragoza, Spain), and the ImmunoCard STAT!

    Article Title: Impact of the COVID-19 Pandemic on Clostridioides difficile Infection Rates in a Tertiary Hospital: A Retrospective Comparative Study
    Article Snippet: Initial screening used the TECHLAB® C. DIFF QUIK CHEK COMPLETETM to detect glutamate dehydrogenase (GDH) antigen and Toxins A and B.

    Article Title: Risk factors for the development of Clostridioides difficile infection in patients colonized with toxigenic Clostridioides difficile
    Article Snippet: Testing for CDI was performed on unformed stool samples using a two-step algorithm; glutamate dehydrogenase (GDH) testing followed by confirmatory EIA (C. Diff Quik Chek Complete; TechLab, Blacksburg, VA), consistent with guideline-recommended algorithms by performing a highly sensitive test first, followed by a highly specific test.

    Article Title: Shigella flexneri Outbreak at a Rehabilitation Center: First Report from Saudi Arabia.
    Article Snippet: Additionally, the stool tested negative for Clostridium difficile toxin using C. DIFF QUIK CHEK COMPLETE ® (TECHLAB, Inc., Blacksburg, VA, USA) on three different samples collected on different days.

    Article Title: Evaluation of a Fluorescence Immunoassay for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxin Antigens.
    Article Snippet: Samples were concurrently tested using the Sofia 2 C. difficile FIA (Sofia 2, QuidelOrtho) and C. diff Quik Chek Complete (QCC, Techlab Inc.).

    Surround Optical-fiber Immunoassay:

    Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection.
    Article Snippet: TABLE 1 Detection of GDH and toxins A/B with three rapid immunoassays compared to tcdA detection with the Alethia C. difficile (Meridian) Consecutive samples, n = 57 Frozen samples (positive with Alethia), n = 47 Alethia C. difficile (Meridian) 14 47 C. diff Quik Chek Complete (Techlab) GDH 14 43 Toxin A/B 10 26 Clostridium difficile GDH + Toxin A + B (Certest) GDH 14/1a 42 Toxin A/B 7/1a 18 Immunocard STAT!

    Article Title: Antibiotic De-Escalation in the Intensive Care Unit: Rationale and Potential Strategies
    Article Snippet: Enzyme immunoassay , Enzyme-linked immunosorbent assay , Techlab C. Diff Quik Chek Complete , Stool , 1 , .

    Article Title: Clinical and Microbiological Characteristics of Hospitalized Adults Aged ≤ 45 Years With Clostridioides (Formerly Clostridium ) difficile Infection: A Prospective Observational Cohort Study From Hungary
    Article Snippet: Diagnosis was made by a clinically compatible case presentation (diarrhea, ileus, toxic megacolon or CDI associated sepsis) plus confirmation of a toxin‐producing C. difficile strain from an unformed stool sample, using enzyme immuno‐assay targeting glutamate dehydrogenase and toxins A + B (C. Diff Quik Chek Complete, TECHLAB Inc.) [ ].

    Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection.
    Article Snippet: In this study, we evaluated the C. diff Quik Chek Complete (TechLab, Blacksburg, Virginia, USA), the CerTest Clostridium difficile GDH +Toxin A + B (CerTest, San Mateo de Gállego, Zaragoza, Spain), and the ImmunoCard STAT!

    Article Title: Impact of the COVID-19 Pandemic on Clostridioides difficile Infection Rates in a Tertiary Hospital: A Retrospective Comparative Study
    Article Snippet: Initial screening used the TECHLAB® C. DIFF QUIK CHEK COMPLETETM to detect glutamate dehydrogenase (GDH) antigen and Toxins A and B.

    Article Title: Risk factors for the development of Clostridioides difficile infection in patients colonized with toxigenic Clostridioides difficile
    Article Snippet: Testing for CDI was performed on unformed stool samples using a two-step algorithm; glutamate dehydrogenase (GDH) testing followed by confirmatory EIA (C. Diff Quik Chek Complete; TechLab, Blacksburg, VA), consistent with guideline-recommended algorithms by performing a highly sensitive test first, followed by a highly specific test.

    Article Title: Shigella flexneri Outbreak at a Rehabilitation Center: First Report from Saudi Arabia.
    Article Snippet: Additionally, the stool tested negative for Clostridium difficile toxin using C. DIFF QUIK CHEK COMPLETE ® (TECHLAB, Inc., Blacksburg, VA, USA) on three different samples collected on different days.

    Article Title: Evaluation of a Fluorescence Immunoassay for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxin Antigens.
    Article Snippet: Samples were concurrently tested using the Sofia 2 C. difficile FIA (Sofia 2, QuidelOrtho) and C. diff Quik Chek Complete (QCC, Techlab Inc.).



    Similar Products

    diff quik staining method  (Sysmex Corporation)
    86
    Sysmex Corporation diff quik staining method
    Inflammatory cell counts in nasal and bronchoalveolar lavage fluids (NALF and BALF) following single or combined exposure to PM2.5, Zn, and formaldehyde in a murine model of allergic rhinitis. (A) Total and differential cell counts, including eosinophils, neutrophils, lymphocytes, and monocytes, were measured in NALF from non-sensitized mice after single intranasal exposure to PM2.5, Zn, or formaldehyde. (B) Total and differential cell counts were assessed in BALF from the same non-sensitized mice following identical single exposures. (C) In ovalbumin (OVA)-sensitized mice, total and differential cell counts in NALF were evaluated after additional intranasal exposure to PM2.5 alone or in combination with Zn or formaldehyde. (D) Total and differential cell counts in BALF were measured in the same OVA-sensitized mice after combined exposures. Inflammatory cells were identified based on morphological characteristics <t>using</t> <t>Diff-Quik</t> staining. Values are presented as mean±standard deviation. NS, not significant. Statistical analysis was conducted with one-way analysis of variance followed by Tukey’s post hoc test. * P <0.05, ** P <0.01, *** P <0.001 vs. OVA or OVA+PM2.5, as indicated.
    Diff Quik Staining Method, supplied by Sysmex Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/diff-quik+staining+method/diff+quik/pmc12973492-50-5-8
    Average 86 stars, based on 1 article reviews
    diff quik staining method - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    diff-quik stained method  (Anhui Anke)
    90
    Anhui Anke diff-quik stained method
    Inflammatory cell counts in nasal and bronchoalveolar lavage fluids (NALF and BALF) following single or combined exposure to PM2.5, Zn, and formaldehyde in a murine model of allergic rhinitis. (A) Total and differential cell counts, including eosinophils, neutrophils, lymphocytes, and monocytes, were measured in NALF from non-sensitized mice after single intranasal exposure to PM2.5, Zn, or formaldehyde. (B) Total and differential cell counts were assessed in BALF from the same non-sensitized mice following identical single exposures. (C) In ovalbumin (OVA)-sensitized mice, total and differential cell counts in NALF were evaluated after additional intranasal exposure to PM2.5 alone or in combination with Zn or formaldehyde. (D) Total and differential cell counts in BALF were measured in the same OVA-sensitized mice after combined exposures. Inflammatory cells were identified based on morphological characteristics <t>using</t> <t>Diff-Quik</t> staining. Values are presented as mean±standard deviation. NS, not significant. Statistical analysis was conducted with one-way analysis of variance followed by Tukey’s post hoc test. * P <0.05, ** P <0.01, *** P <0.001 vs. OVA or OVA+PM2.5, as indicated.
    Diff Quik Stained Method, supplied by Anhui Anke, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/diff-quik+staining+method/diff+quick+staining/pmc12101436-74-13-17
    Average 90 stars, based on 1 article reviews
    diff-quik stained method - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    sperm morphology stain kit (diff-quik method)  (Beijing Solarbio Science)
    90
    Beijing Solarbio Science sperm morphology stain kit (diff-quik method)
    Inflammatory cell counts in nasal and bronchoalveolar lavage fluids (NALF and BALF) following single or combined exposure to PM2.5, Zn, and formaldehyde in a murine model of allergic rhinitis. (A) Total and differential cell counts, including eosinophils, neutrophils, lymphocytes, and monocytes, were measured in NALF from non-sensitized mice after single intranasal exposure to PM2.5, Zn, or formaldehyde. (B) Total and differential cell counts were assessed in BALF from the same non-sensitized mice following identical single exposures. (C) In ovalbumin (OVA)-sensitized mice, total and differential cell counts in NALF were evaluated after additional intranasal exposure to PM2.5 alone or in combination with Zn or formaldehyde. (D) Total and differential cell counts in BALF were measured in the same OVA-sensitized mice after combined exposures. Inflammatory cells were identified based on morphological characteristics <t>using</t> <t>Diff-Quik</t> staining. Values are presented as mean±standard deviation. NS, not significant. Statistical analysis was conducted with one-way analysis of variance followed by Tukey’s post hoc test. * P <0.05, ** P <0.01, *** P <0.001 vs. OVA or OVA+PM2.5, as indicated.
    Sperm Morphology Stain Kit (Diff Quik Method), supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/diff-quik+staining+method/sperm+morphology+stain+kit++diff+quik+method+/pm40268268-83-10-16
    Average 90 stars, based on 1 article reviews
    sperm morphology stain kit (diff-quik method) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    sperm morphology stain kit diff-quik method  (Beijing Solarbio Science)
    90
    Beijing Solarbio Science sperm morphology stain kit diff-quik method
    Inflammatory cell counts in nasal and bronchoalveolar lavage fluids (NALF and BALF) following single or combined exposure to PM2.5, Zn, and formaldehyde in a murine model of allergic rhinitis. (A) Total and differential cell counts, including eosinophils, neutrophils, lymphocytes, and monocytes, were measured in NALF from non-sensitized mice after single intranasal exposure to PM2.5, Zn, or formaldehyde. (B) Total and differential cell counts were assessed in BALF from the same non-sensitized mice following identical single exposures. (C) In ovalbumin (OVA)-sensitized mice, total and differential cell counts in NALF were evaluated after additional intranasal exposure to PM2.5 alone or in combination with Zn or formaldehyde. (D) Total and differential cell counts in BALF were measured in the same OVA-sensitized mice after combined exposures. Inflammatory cells were identified based on morphological characteristics <t>using</t> <t>Diff-Quik</t> staining. Values are presented as mean±standard deviation. NS, not significant. Statistical analysis was conducted with one-way analysis of variance followed by Tukey’s post hoc test. * P <0.05, ** P <0.01, *** P <0.001 vs. OVA or OVA+PM2.5, as indicated.
    Sperm Morphology Stain Kit Diff Quik Method, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/diff-quik+staining+method/diff+quik/10__1016_slash_j__aquaculture__2024__741985-114-28-34
    Average 90 stars, based on 1 article reviews
    sperm morphology stain kit diff-quik method - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    diff - quik staining method sperm morphology staining kit  (Anhui Anke)
    90
    Anhui Anke diff - quik staining method sperm morphology staining kit
    Inflammatory cell counts in nasal and bronchoalveolar lavage fluids (NALF and BALF) following single or combined exposure to PM2.5, Zn, and formaldehyde in a murine model of allergic rhinitis. (A) Total and differential cell counts, including eosinophils, neutrophils, lymphocytes, and monocytes, were measured in NALF from non-sensitized mice after single intranasal exposure to PM2.5, Zn, or formaldehyde. (B) Total and differential cell counts were assessed in BALF from the same non-sensitized mice following identical single exposures. (C) In ovalbumin (OVA)-sensitized mice, total and differential cell counts in NALF were evaluated after additional intranasal exposure to PM2.5 alone or in combination with Zn or formaldehyde. (D) Total and differential cell counts in BALF were measured in the same OVA-sensitized mice after combined exposures. Inflammatory cells were identified based on morphological characteristics <t>using</t> <t>Diff-Quik</t> staining. Values are presented as mean±standard deviation. NS, not significant. Statistical analysis was conducted with one-way analysis of variance followed by Tukey’s post hoc test. * P <0.05, ** P <0.01, *** P <0.001 vs. OVA or OVA+PM2.5, as indicated.
    Diff Quik Staining Method Sperm Morphology Staining Kit, supplied by Anhui Anke, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/diff-quik+staining+method/sperm+dna+fragmentation++sdf++staining+kit/pmc11790627-150-16-20
    Average 90 stars, based on 1 article reviews
    diff - quik staining method sperm morphology staining kit - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    diff-quik staining method  (Siemens Healthineers)
    90
    Siemens Healthineers diff-quik staining method
    Inflammatory cell counts in nasal and bronchoalveolar lavage fluids (NALF and BALF) following single or combined exposure to PM2.5, Zn, and formaldehyde in a murine model of allergic rhinitis. (A) Total and differential cell counts, including eosinophils, neutrophils, lymphocytes, and monocytes, were measured in NALF from non-sensitized mice after single intranasal exposure to PM2.5, Zn, or formaldehyde. (B) Total and differential cell counts were assessed in BALF from the same non-sensitized mice following identical single exposures. (C) In ovalbumin (OVA)-sensitized mice, total and differential cell counts in NALF were evaluated after additional intranasal exposure to PM2.5 alone or in combination with Zn or formaldehyde. (D) Total and differential cell counts in BALF were measured in the same OVA-sensitized mice after combined exposures. Inflammatory cells were identified based on morphological characteristics <t>using</t> <t>Diff-Quik</t> staining. Values are presented as mean±standard deviation. NS, not significant. Statistical analysis was conducted with one-way analysis of variance followed by Tukey’s post hoc test. * P <0.05, ** P <0.01, *** P <0.001 vs. OVA or OVA+PM2.5, as indicated.
    Diff Quik Staining Method, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/diff-quik+staining+method/diff+quik+stain+set/pm29198956-44-2-5
    Average 90 stars, based on 1 article reviews
    diff-quik staining method - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    diff-quik staining method  (Baxter Healthcare)
    90
    Baxter Healthcare diff-quik staining method
    Inflammatory cell counts in nasal and bronchoalveolar lavage fluids (NALF and BALF) following single or combined exposure to PM2.5, Zn, and formaldehyde in a murine model of allergic rhinitis. (A) Total and differential cell counts, including eosinophils, neutrophils, lymphocytes, and monocytes, were measured in NALF from non-sensitized mice after single intranasal exposure to PM2.5, Zn, or formaldehyde. (B) Total and differential cell counts were assessed in BALF from the same non-sensitized mice following identical single exposures. (C) In ovalbumin (OVA)-sensitized mice, total and differential cell counts in NALF were evaluated after additional intranasal exposure to PM2.5 alone or in combination with Zn or formaldehyde. (D) Total and differential cell counts in BALF were measured in the same OVA-sensitized mice after combined exposures. Inflammatory cells were identified based on morphological characteristics <t>using</t> <t>Diff-Quik</t> staining. Values are presented as mean±standard deviation. NS, not significant. Statistical analysis was conducted with one-way analysis of variance followed by Tukey’s post hoc test. * P <0.05, ** P <0.01, *** P <0.001 vs. OVA or OVA+PM2.5, as indicated.
    Diff Quik Staining Method, supplied by Baxter Healthcare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/diff-quik+staining+method/diff+quik/pm28214572-57-1-6
    Average 90 stars, based on 1 article reviews
    diff-quik staining method - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Inflammatory cell counts in nasal and bronchoalveolar lavage fluids (NALF and BALF) following single or combined exposure to PM2.5, Zn, and formaldehyde in a murine model of allergic rhinitis. (A) Total and differential cell counts, including eosinophils, neutrophils, lymphocytes, and monocytes, were measured in NALF from non-sensitized mice after single intranasal exposure to PM2.5, Zn, or formaldehyde. (B) Total and differential cell counts were assessed in BALF from the same non-sensitized mice following identical single exposures. (C) In ovalbumin (OVA)-sensitized mice, total and differential cell counts in NALF were evaluated after additional intranasal exposure to PM2.5 alone or in combination with Zn or formaldehyde. (D) Total and differential cell counts in BALF were measured in the same OVA-sensitized mice after combined exposures. Inflammatory cells were identified based on morphological characteristics using Diff-Quik staining. Values are presented as mean±standard deviation. NS, not significant. Statistical analysis was conducted with one-way analysis of variance followed by Tukey’s post hoc test. * P <0.05, ** P <0.01, *** P <0.001 vs. OVA or OVA+PM2.5, as indicated.

    Journal: Clinical and Experimental Otorhinolaryngology

    Article Title: Synergistic Exacerbation of Allergic Inflammation by Combined Exposure to Air-Pollutants in a Murine Model of Allergic Rhinitis

    doi: 10.21053/ceo.2025-00170

    Figure Lengend Snippet: Inflammatory cell counts in nasal and bronchoalveolar lavage fluids (NALF and BALF) following single or combined exposure to PM2.5, Zn, and formaldehyde in a murine model of allergic rhinitis. (A) Total and differential cell counts, including eosinophils, neutrophils, lymphocytes, and monocytes, were measured in NALF from non-sensitized mice after single intranasal exposure to PM2.5, Zn, or formaldehyde. (B) Total and differential cell counts were assessed in BALF from the same non-sensitized mice following identical single exposures. (C) In ovalbumin (OVA)-sensitized mice, total and differential cell counts in NALF were evaluated after additional intranasal exposure to PM2.5 alone or in combination with Zn or formaldehyde. (D) Total and differential cell counts in BALF were measured in the same OVA-sensitized mice after combined exposures. Inflammatory cells were identified based on morphological characteristics using Diff-Quik staining. Values are presented as mean±standard deviation. NS, not significant. Statistical analysis was conducted with one-way analysis of variance followed by Tukey’s post hoc test. * P <0.05, ** P <0.01, *** P <0.001 vs. OVA or OVA+PM2.5, as indicated.

    Article Snippet: Slides were stained using the Diff-Quik staining method (Sysmex).

    Techniques: Diff-Quik, Staining, Standard Deviation